Feedback PLC Bleepa appointed to major NHSx framework (6621U)
30 Juli 2020 - 4:48PM
UK Regulatory
TIDMFDBK
RNS Number : 6621U
Feedback PLC
30 July 2020
Prior to publication, the information contained within this
announcement was deemed by the Company to constitute inside
information as stipulated under the Market Abuse Regulations (EU)
No. 596/2014 ("MAR"). With the publication of this announcement,
this information is now considered to be in the public domain.
Feedback plc
Bleepa (R) to lead clinical communications revolution through
appointment to major NHSx framework
-- NHSx Clinical Communication Tool Framework endorses Bleepa and provides route to payment
-- The Directors believe that as the only CE marked product for
digital patient imaging on the framework Bleepa is the only
provider that can deliver digital imaging as part of the
communication service
London, 30 July 2020: Feedback plc (AIM: FDBK, "Feedback" or the
"Company"), the specialist medical imaging technology company,
today announces that its flagship imaging-based communication
platform, Bleepa, has been awarded a place on the NHSx National
Clinical Communication Tool Framework ("the NCCT Framework").
Bleepa is a clinical communications platform that combines access
to review quality medical imaging alongside instant messaging and
video calling in one CE marked, zero footprint, medical device.
The NCCT Framework provides a vehicle for NHS Trusts to buy
Bleepa by drawing down from a GBP3 million centralised fund over a
two year period. It gives Bleepa national coverage and provides an
independent validation of the quality and suitability of Bleepa for
frontline delivery, a stamp of approval that the Company can use to
also drive sales in other markets.
The Directors believe that as the only CE marked medical device
relating to medical imaging on the NCCT Framework, Bleepa is the
only supplier able to deliver digital patient imaging for
diagnostic purposes alongside clinical messaging. The Directors
believe that Bleepa's simple messaging exchange will offer
considerable benefit to clinicians and Trusts, enabling the NHS to
purge the pager and replace it with a truly transformative solution
that brings medical imaging into routine communication.
Dr Tom Oakley, CEO of Feedback, commented:
"Bleepa has set a new standard for medical communication tools.
I am delighted Bleepa has been awarded a place on the NHSx Clinical
Communication Tool framework which positions Bleepa in the vanguard
of medical imaging communications and provides a vehicle for
potential reimbursement whilst simultaneously making Bleepa
available to the whole of the NHS."
# # #
Below is the full announcement made today by NHSx:
Clinical Communications Procurement Framework
The Procurement Framework aims to support NHS organisations with
dedicated clinical facing communication and tasks management tools,
to accelerate the adoption of proven technologies and to phase out
pagers by the end of 2021.
The framework has been designed to provide a compliant and
convenient route to market for all NHS organisations.
It allows clinicians to access a wide range of communication
tools all under one procurement framework agreement. Participating
authorities have the freedom and flexibility to make a direct award
or undertake a mini-competition to meet the bespoke requirement of
each customer.
The suppliers have been assessed to ensure that they meet all
legislative requirements; therefore no formal tendering is
required, saving valuable time and money in the procurement
process. The framework contains large national companies but also a
healthy number of regional SMEs, and all can showcase their
products via the framework, helping buyers to make informed local
decisions.
Framework date and duration
3 August 2020 to 3 August 2022. Possible further extension for
12 months.
Further information is available on the NHSx website at
https://www.nhsx.nhs.uk/key-tools-and-info/clinical-communications-procurement-framework/
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited (Joint
Broker)
Patrick Claridge / John Howes +44 20 3815 8880
Instinctif Partners +44 (0)20 7457 2020
Melanie Toyne-Sewell / Phillip Marriage +44 7890 022 814
feedbackplc@instinctif.com
Notes to editors
About Bleepa
Bleepa provides instant and remote access to clinical grade
medical images through a zero footprint application. The majority
of patient cases require medical imaging which can be seamlessly
shared to the entire clinical team through Bleepa. Cases can be
discussed through its secure instant messaging and image
annotation, allowing comments and treatment decisions to be
communicated instantly between team members. Bleepa can be accessed
from any internet connected device including phones, tablets,
laptops and desktops; clinicians can use their own devices and
therefore no additional hardware is required.
About Feedback plc - www.fbk.com
Feedback plc (AIM: FDBK) is a specialist medical imaging
technology company providing innovative software and systems,
through its fully owned trading subsidiary, Feedback Medical
Limited. Its products advance the work of radiologists, clinicians
and medical researchers by improving workflows and giving unique
insights into diseases, particularly cancer.
Feedback has launched Bleepa, a new secure, encrypted medical
communication app for clinicians accessible through smartphones,
tablets and desktops that facilitates rapid clinical messaging and
review of medical grade imaging for all members of a clinical team,
directly from a hospital Picture Archiving and Communications
System (PACS). For more information on Bleepa, see www.bleepa.com
.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCKKKBQQBKDAON
(END) Dow Jones Newswires
July 30, 2020 10:48 ET (14:48 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024